Search for Clinical Trials

BRIDGE Study (EA8212): Intravesical BCG vs GEMDOCE in non-muscle invasive bladder cancer (H-54036)
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
GLOFIT: Evaluating Glofitamab + Gemcitabine + Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (H-55651)
GLOFIT: A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
View Clinical Trial
ROADS: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile (H-55154)
ROADS Trial: A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (…
  • Brain/Spinal Cord/Nervous System
  • Cancer - All
  • Cancer - Brain
  • Neurology
View Clinical Trial
PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer (H-56035)
S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-…
  • Cancer - All
  • Cancer - Gastric/Stomach
  • Digestive System
View Clinical Trial
A031803: Testing the Addition of Pembrolizumab to Gemcitabine for BCG-Unresponsive Non-muscle Invasive Bladder Cancer (H-50373)
A031803: Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
BN011: Testing the Addition of the Drug Lomustine to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma (H-52827)
NRG-BN011:  A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients With Methylated MGMT…
  • Cancer - All
  • Cancer - Brain
  • Neurology
View Clinical Trial
PROBE Trial: Comparing Immunotherapy-Based Drug Combination With or Without Surgery in Metastatic Kidney Cancer (H-51920)
Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial…
  • Cancer - All
  • Cancer - Kidney/Renal
View Clinical Trial
MajesTEC-9: Teclistamab Monotherapy vs Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (H-53936)
MajesTEC-9: A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib,…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Myeloma
View Clinical Trial
TAILOR RT: Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (H-50043)
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerThe purpose of this study is to…
  • Cancer - All
  • Cancer - Breast
View Clinical Trial
CIRCULATE-US: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (H-52559)
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor…
  • Cancer - All
  • Cancer - Colon/Rectal
View Clinical Trial